Palisade Bio (PALI) on Wednesday filed a registration statement with the US Securities and Exchange Commission for a public offering of shares or pre-funded warrants.
The actual size and pricing of the offering are yet to be determined.
Pre-funded warrants will be offered to shareholders owning more than a 4.99% stake in the company after buying common shares under the offering. Each pre-funded warrant allows for one common share upon exercise, the company said.
Palisade shares fell 8% in recent trading.
Price: 3.11, Change: -0.27, Percent Change: -8.02
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments